IRP_USA_ALS Blog Post Image

Market access is the ultimate goal for medical device and pharmaceutical companies, yet it remains one of the biggest current and future challenges for the industry. Spiraling drug development costs mean the pressure is on to ensure successful and effective market access.


To uncover the specifics on the challenges and key success factors, we recently conducted a survey with global and local stakeholders to find out more. 91 stakeholders were included from a variety of pharmaceutical and medical device roles in pricing, reimbursement, market access, health economics outcomes research (HEOR) and policy.